ADIPOQ and Insulin resistance: It has been demonstrated that patients with AN have significantly decreased plasma leptin and markedly increased plasma adiponectin levels [89], and the increased adiponectin levels may serve as a compensatory mechanism for insulin resistance in patients with AN [107].